Company / Tangible Book Value per Share
Kura Oncology, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.23
FY2025
5-year range
$2.23 / $7.64
FY2021-FY2025
Trend
-60.0%
vs FY2024
Sector context
#140 of 209
Health Care
What the data says
At $2.23, Kura Oncology, Inc.'s tangible book value per share ranks #140 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $2.23 in FY2025 to $11.51 in FY2020.
Based on SEC 10-K filings.
2.23 in FY2025 with a 5-year CAGR of -28.0%.
Declined from $5.43 to $2.23 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -29.2%
- 5-Year CAGR
- -28.0%
- 10-Year CAGR
- -
Sector benchmark
#140 of 209 in Health CareTop 67% of 209This company $2.23 Sector average $93.47
▼
-97.6% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 60.0% year-over-year.
- Ranks #140 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.23 | -60.0% |
| FY2024 | $5.56 | +2.5% |
| FY2023 | $5.43 | -13.5% |
| FY2022 | $6.27 | -17.8% |
| FY2021 | $7.64 | -33.7% |
| FY2020 | $11.51 | +120.7% |
| FY2019 | $5.22 | +14.0% |
| FY2018 | $4.57 | +33.1% |
| FY2017 | $3.44 | +13.0% |
| FY2016 | $3.04 | -63.2% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026